226 related articles for article (PubMed ID: 22266855)
21. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
23. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions.
Chambliss KL; Simon L; Yuhanna IS; Mineo C; Shaul PW
Mol Endocrinol; 2005 Feb; 19(2):277-89. PubMed ID: 15486047
[TBL] [Abstract][Full Text] [Related]
25. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between EGFR and extranuclear steroid receptors.
Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F
Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767
[TBL] [Abstract][Full Text] [Related]
27. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
[TBL] [Abstract][Full Text] [Related]
28. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II.
Liu J; Rothermund CA; Ayala-Sanmartin J; Vishwanatha JK
BMC Biochem; 2003 Sep; 4():10. PubMed ID: 12962548
[TBL] [Abstract][Full Text] [Related]
29. Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell line.
Takahashi T; Ohmichi M; Kawagoe J; Ohshima C; Doshida M; Ohta T; Saitoh M; Mori-Abe A; Du B; Igarashi H; Takahashi K; Kurachi H
Endocrinology; 2005 Sep; 146(9):4082-9. PubMed ID: 15947004
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
[TBL] [Abstract][Full Text] [Related]
31. An inherent role of microtubule network in the action of nuclear receptor.
Manavathi B; Acconcia F; Rayala SK; Kumar R
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15981-6. PubMed ID: 17043237
[TBL] [Abstract][Full Text] [Related]
32. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
33. Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.
Zheng FF; Wu RC; Smith CL; O'Malley BW
Mol Cell Biol; 2005 Sep; 25(18):8273-84. PubMed ID: 16135815
[TBL] [Abstract][Full Text] [Related]
34. IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells.
Cervantes-Badillo MG; Paredes-Villa A; Gómez-Romero V; Cervantes-Roldán R; Arias-Romero LE; Villamar-Cruz O; González-Montiel M; Barrios-García T; Cabrera-Quintero AJ; Rodríguez-Gómez G; Cancino-Villeda L; Zentella-Dehesa A; León-Del-Río A
Front Endocrinol (Lausanne); 2020; 11():568375. PubMed ID: 33117284
[TBL] [Abstract][Full Text] [Related]
35. Nucleocytoplasmic shuttling of persistently activated STAT3.
Herrmann A; Vogt M; Mönnigmann M; Clahsen T; Sommer U; Haan S; Poli V; Heinrich PC; Müller-Newen G
J Cell Sci; 2007 Sep; 120(Pt 18):3249-61. PubMed ID: 17726064
[TBL] [Abstract][Full Text] [Related]
36. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
[TBL] [Abstract][Full Text] [Related]
37. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
Gong EY; Park E; Lee K
Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
[TBL] [Abstract][Full Text] [Related]
38. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
39. Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.
Zhang XT; Ding L; Kang LG; Wang ZY
Oncol Rep; 2012 Jun; 27(6):2057-65. PubMed ID: 22426783
[TBL] [Abstract][Full Text] [Related]
40. Novel role for PINX1 as a coregulator of nuclear hormone receptors.
Noriega-Reyes MY; Rivas-Torres MA; Oñate-Ocaña LF; Vallés AJ; Baranda-Avila N; Langley E
Mol Cell Endocrinol; 2015 Oct; 414():9-18. PubMed ID: 26187699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
